Molecular mechanisms of cocaine reward: Combined dopamine and serotonin transporter knockouts eliminate cocaine place preference

Cocaine blocks uptake by neuronal plasma membrane transporters for dopamine (DAT), serotonin (SERT), and norepinephrine (NET). Cocaine reward/reinforcement has been linked to actions at DAT or to blockade of SERT. However, knockouts of neither DAT, SERT, or NET reduce cocaine reward/reinforcement, leaving substantial uncertainty about cocaine's molecular mechanisms for reward. Conceivably, the molecular bases of cocaine reward might display sufficient redundancy that either DAT or SERT might be able to mediate cocaine reward in the other's absence. To test this hypothesis, we examined double knockout mice with deletions of one or both copies of both the DAT and SERT genes. These mice display viability, weight gain, histologic features, neurochemical parameters, and baseline behavioral features that allow tests of cocaine influences. Mice with even a single wild-type DAT gene copy and no SERT copies retain cocaine reward/reinforcement, as measured by conditioned place-preference testing. However, mice with no DAT and either no or one SERT gene copy display no preference for places where they have previously received cocaine. The serotonin dependence of cocaine reward in DAT knockout mice is thus confirmed by the elimination of cocaine place preference in DAT/SERT double knockout mice. These results provide insights into the brain molecular targets necessary for cocaine reward in knockout mice that develop in their absence and suggest novel strategies for anticocaine medication development.

[1]  B. Pitt Psychopharmacology , 1968, Mental Health.

[2]  Irwin J. Kopin,et al.  The Biochemical Basis of Neuropharmacology , 1971, The Yale Journal of Biology and Medicine.

[3]  Proceedings: Role of norepinephrine, dopamine, and serotonin in intracranial reward. , 1974 .

[4]  E. Miliaressis Serotonergic basis of reward in median raphé of the rat , 1977, Pharmacology Biochemistry and Behavior.

[5]  H. Fibiger,et al.  On the role of ascending catecholaminergic systems in intravenous self-administration of cocaine , 1977, Pharmacology Biochemistry and Behavior.

[6]  P. Redgrave Modulation of intracranial self-stimulation behaviour by local perfusions of dopamine, noradrenaline and serotonin within the caudate nucleus and nucleus accumbens , 1978, Brain Research.

[7]  Dependence potential of buprenorphine studied in rhesus monkeys. , 1982, NIDA research monograph.

[8]  G. Koob,et al.  Disruption of cocaine self-administration following 6-hydroxydopamine lesions of the ventral tegmental area in rats , 1982, Pharmacology Biochemistry and Behavior.

[9]  Alcohol , 1984, Peptides.

[10]  S. Snyder,et al.  [3H]mazindol binding associated with neuronal dopamine and norepinephrine uptake sites. , 1984, Molecular pharmacology.

[11]  E. Uhlenhuth,et al.  Reinforcing and subjective effects of several anorectics in normal human volunteers. , 1987, The Journal of pharmacology and experimental therapeutics.

[12]  J. Marcusson,et al.  Characterization of [3H]Paroxetine Binding in Rat Brain , 1988, Journal of neurochemistry.

[13]  G. Di Chiara,et al.  Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[14]  G. Nomikos,et al.  Effects of ritanserin on the rewarding properties of d-amphetamine, morphine and diazepam revealed by conditioned place preference in rats , 1988, Pharmacology Biochemistry and Behavior.

[15]  Chronic imipramine does not block cocaine-induced increases in brain stimulation reward , 1989, Pharmacology Biochemistry and Behavior.

[16]  R. Spealman,et al.  Effects of cocaine and related drugs in nonhuman primates. II. Stimulant effects on schedule-controlled behavior. , 1989, The Journal of pharmacology and experimental therapeutics.

[17]  M. Terai,et al.  Comparison of [3H]YM-09151-2 with [3H]spiperone and [3H]raclopride for dopamine d-2 receptor binding to rat striatum. , 1989, European journal of pharmacology.

[18]  A. Frazer,et al.  [3H]nisoxetine: a new radioligand for norepinephrine uptake sites in brain. , 1990, European journal of pharmacology.

[19]  M. Kuhar,et al.  New, potent cocaine analogs: ligand binding and transport studies in rat striatum. , 1990, European journal of pharmacology.

[20]  M. Kuhar,et al.  Cocaine inhibition of ligand binding at dopamine, norepinephrine and serotonin transporters: a structure-activity study. , 1990, Life sciences.

[21]  M. J. Kuhar,et al.  The dopamine hypothesis of the reinforcing properties of cocaine , 1991, Trends in Neurosciences.

[22]  F. J. White,et al.  Cocaine : pharmacology, physiology, and clinical strategies , 1992 .

[23]  K. Johnson,et al.  Neurobiology of cocaine abuse. , 1992, Trends in pharmacological sciences.

[24]  G. Uhl,et al.  Transporter explosion: update on uptake. , 1992, Trends in pharmacological sciences.

[25]  Cocaine: Pharmacology, Physiology and Clinical Strategies , 1993 .

[26]  G. Uhl,et al.  Dopamine transporter mutants selectively enhance MPP+ transport , 1993, Synapse.

[27]  A. Andrews,et al.  Sustained Depletion of Cortical and Hippocampal Serotonin and Norepinephrine but Not Striatal Dopamine by 1‐Methyl‐4‐(2′‐Aminophenyl)‐1,2,3,6‐Tetrahydropyridine (2′‐NH2‐MPTP): A Comparative Study with 2′‐CH3‐MPTP and MPTP , 1993, Journal of neurochemistry.

[28]  S. Tella Effects of monoamine reuptake inhibitors on cocaine self-administration in rats , 1995, Pharmacology Biochemistry and Behavior.

[29]  D. Calcagnetti,et al.  Blockade of cocaine-induced conditioned place preference: relevance to cocaine abuse therapeutics. , 1995, Life sciences.

[30]  P. Fletcher,et al.  Median raphe injections of 8-OH-DPAT lower frequency thresholds for lateral hypothalamic self-stimulation , 1995, Pharmacology Biochemistry and Behavior.

[31]  G. Fillion,et al.  Effects of stress on the functional properties of pre- and postsynaptic 5-HT1B receptors in the rat brain. , 1995, European journal of pharmacology.

[32]  George R. Uhl,et al.  Drug addiction: Knockout mice and dirty drugs , 1996, Current Biology.

[33]  L. Parsons,et al.  Serotonin1B receptor stimulation enhances dopamine-mediated reinforcement , 1996, Psychopharmacology.

[34]  R. Mark Wightman,et al.  Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter , 1996, Nature.

[35]  E. Borrelli,et al.  Absence of opiate rewarding effects in mice lacking dopamine D2 receptors , 1997, Nature.

[36]  W. Wetsel,et al.  Anterior Pituitary Hypoplasia and Dwarfism in Mice Lacking the Dopamine Transporter , 1997, Neuron.

[37]  L. Parsons,et al.  Serotonin1B Receptor Stimulation Enhances Cocaine Reinforcement , 1998, The Journal of Neuroscience.

[38]  D. Murphy,et al.  Altered brain serotonin homeostasis and locomotor insensitivity to 3, 4-methylenedioxymethamphetamine ("Ecstasy") in serotonin transporter-deficient mice. , 1998, Molecular pharmacology.

[39]  A. Pert Neurobiological substrates underlying conditioned effects of cocaine. , 1998, Advances in pharmacology.

[40]  R. Gainetdinov,et al.  Cocaine self-administration in dopamine-transporter knockout mice , 1998, Nature Neuroscience.

[41]  J. Neill,et al.  An investigation into the effects of 5-HT agonists and receptor antagonists on ethanol self-administration in the rat. , 1998, Alcohol.

[42]  R. Hen,et al.  Increased vulnerability to cocaine in mice lacking the serotonin-1B receptor , 1998, Nature.

[43]  M. Low,et al.  Alcohol preference and sensitivity are markedly reduced in mice lacking dopamine D2 receptors , 1998, Nature Neuroscience.

[44]  T. Tzschentke,et al.  Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues , 1998, Progress in Neurobiology.

[45]  D. Murphy,et al.  Cocaine reward models: conditioned place preference can be established in dopamine- and in serotonin-transporter knockout mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[46]  Calcitonin increases 5-HT1A binding site densities in the brain of adrenalectomized rats , 1998, Brain Research.

[47]  G. Uhl,et al.  Dopamine transporter: transmembrane phenylalanine mutations can selectively influence dopamine uptake and cocaine analog recognition. , 1999, Molecular pharmacology.

[48]  S. Childers,et al.  Self-administration of cocaine analogs by rats , 1999, Psychopharmacology.

[49]  L. Parsons,et al.  RU 24969, a 5‐HT1B/1A receptor agonist, potentiates cocaine‐induced increases in nucleus accumbens dopamine , 1999, Synapse.

[50]  H. Meltzer,et al.  The effect of ipsapirone and S(−)-pindolol on dopamine release in rat striatum and nucleus accumbens , 1999, Brain Research.

[51]  A. Harrison,et al.  RU 24969, a 5-HT1A/1B agonist, elevates brain stimulation reward thresholds: an effect reversed by GR 127935, a 5-HT1B/1D antagonist , 1999, Psychopharmacology.

[52]  D. Lorrain,et al.  Lateral Hypothalamic Serotonin Inhibits Nucleus Accumbens Dopamine: Implications for Sexual Satiety , 1999, The Journal of Neuroscience.

[53]  P. Fletcher,et al.  Activation of 5-HT1B receptors in the nucleus accumbens reduces amphetamine-induced enhancement of responding for conditioned reward , 1999, Psychopharmacology.

[54]  D. Baker,et al.  Serotonin depletion attenuates cocaine-seeking behavior in rats , 1999, Psychopharmacology.

[55]  P. De Deurwaerdère,et al.  Role of Serotonin2A and Serotonin2B/2C Receptor Subtypes in the Control of Accumbal and Striatal Dopamine Release Elicited In Vivo by Dorsal Raphe Nucleus Electrical Stimulation , 1999, Journal of neurochemistry.

[56]  E. Noble,et al.  Addiction and its reward process through polymorphisms of the D2 dopamine receptor gene: a review , 2000, European Psychiatry.

[57]  Fei Xu,et al.  Mice lacking the norepinephrine transporter are supersensitive to psychostimulants , 2000, Nature Neuroscience.

[58]  D. Wilkin,et al.  Neuron , 2001, Brain Research.